Expert Advice: 3 Ways To Manage Pain Caused By A Frozen Shoulder

Pain caused by a frozen shoulder can be incredibly debilitating, impeding an individual’s ability to move their arm or shoulder normally. The condition, also known as adhesive capsulitis, is caused by a tightening or thickening of the joint capsule, which leads to a decrease in range of motion. The condition is most common in individuals between the ages of 40 and 70, and can last for several weeks or months.

Consulting experts from Neuragenex for frozen shoulder pain is the best way to manage pain caused by a frozen shoulder. But should the situation call for a bit of self-medication before you are able to see a professional, here are a few things you can do to help manage the pain.

The first step in the management of a frozen shoulder is to understand what is happening to the shoulder joint. It is important to understand the mechanism of the condition to properly assess the best course of treatment going forward. In addition, an understanding of the condition is necessary to ensure proper management, as well as to ensure that the activity or treatment chosen does not exacerbate the condition.

The second step in managing a frozen shoulder is to reduce the pain.

1. Apply Heat or Cold Therapy to reduce pain

One of the most effective ways to manage pain caused by a frozen shoulder is the application of either heat or cold therapy. Heat therapy can help relax your shoulder muscles and relieve tension, while cold therapy can reduce inflammation and numb pain. Heat therapy can be applied in the form of hot packs, hot baths, or heated wraps, while cold therapy can be applied in the form of cold packs, cold baths, or cold wraps. You should also aim to do specific stretching and strengthening exercises to help improve your range of motion and reduce your pain.

When it comes to cold therapy for frozen shoulders, another effective method is the use of an ice submersion tank. This involves immersing the affected shoulder in a tank of ice-cold water for several minutes at a time, which can help to reduce inflammation and provide pain relief. However, it’s important to note that this method should only be used under the guidance of a healthcare professional, as prolonged exposure to cold water can lead to hypothermia or other adverse effects. Always follow your healthcare provider’s recommendations for the safest and most effective pain management strategies for your frozen shoulder.

2. Perform Range of Motion Exercises to increase flexibility

Range of motion exercises is effective for helping to improve flexibility and reduce pain caused by a frozen shoulder. It is important to perform these exercises correctly to ensure you are not worsening the condition. Start by slowly moving your shoulder in circles both clockwise and counter-clockwise. Do 10 reps in each direction. You can also do shoulder stretches, such as the sleeper stretch, in which you lie on your affected side with your affected arm in front of you, then gently lift your arm up and over your head. Hold for 10-20 seconds, then relax. Repeat 3-4 times. Make sure to keep your body relaxed throughout the exercise.

3. Take Anti-Inflammatory Medication to reduce inflammation

Taking anti-inflammatory medications may help to reduce inflammation and pain associated with a frozen shoulder. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen and aspirin can help to reduce inflammation, swelling, and pain. It is important to consult a doctor before taking any anti-inflammatory medication to ensure that it is appropriate for the individual’s health situation.

In conclusion, managing pain associated with a frozen shoulder can be daunting, but with the right approach and techniques, it is possible to find relief and keep the condition from worsening. The three techniques discussed here are proven to be effective in reducing pain and improving range of motion in the shoulder. However, if the pain persists, it is important to consult with a healthcare professional to determine the best course of treatment for the individual.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”